Current Issue: Featured Articles

Matt_BrunnerHeadshotJune2020
Spotlight Interview: A. Matthew Brunner, MHS, PA-C, DFAAPA
What led you to get involved in planning continuing medical education (CME) conferences? Matthew: As a student of history, I feel the best way to answer this question is to look at these meetings and...
Spotlight Interview: Pamela J. Schell PsyD, MSN, ARNP, DNC
Tell us a little bit about your educational background. Pam: I received my Bachelor of Science in Nursing, Master of Science in Nursing, and Advanced Practice Nursing degrees from Washington State University...
Pam-Schell-Headshot
Editorial Message from Guest Editor Pam J. Schell, PsyD, MSN, ARNP, DNC
Dear Colleagues: Welcome to the inaugural April 2020 edition of NP+PA Perspectives in Dermatology, an ongoing, quarterly supplement series to The Journal of Clinical and Aesthetic Dermatology (JCAD). NP+PA...
JohnsonNPPAApril2020
Managing Rosacea in the Clinic: From Pathophysiology to Treatment—A Review of the Literature
J Clin Aesthet Dermatol. 2020;13(4 Suppl):S17–S22 by Sandra Marchese Johnson, MD, FAAD; Andrew Berg, PA-C; and Chelsea Barr, MPAS, PA-C Dr. Johnson is with Johnson Dermatology in  Fort Smith, Arkansas;...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.